These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34511082)

  • 1. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study.
    Pearce ME; Bartlett SR; Yu A; Lamb J; Reitz C; Wong S; Alvarez M; Binka M; Velásquez Garcia H; Jeong D; Clementi E; Adu P; Samji H; Wong J; Buxton J; Yoshida E; Elwood C; Sauve L; Pick N; Krajden M; Janjua NZ
    BMC Womens Health; 2021 Sep; 21(1):330. PubMed ID: 34511082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
    Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
    EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
    Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
    Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
    Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
    J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
    Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M
    PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men.
    Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ
    Liver Int; 2021 Mar; 41(3):482-493. PubMed ID: 33305525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
    Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.
    Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M
    BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
    Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
    World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019.
    Pearce ME; Yu A; Alvarez M; Bartlett SR; Binka M; Jeong D; Clementi E; Adu P; Wilton J; Yoshida EM; Pick N; Buxton JA; Wong J; Jassem A; Krajden M; Janjua NZ
    PLoS One; 2020; 15(12):e0244575. PubMed ID: 33382774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
    Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
    PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
    Miller LS; Millman AJ; Lom J; Osinubi A; Ahmed F; Dupont S; Rein D; Vellozzi C; Harris AM
    J Viral Hepat; 2020 Jan; 27(1):13-19. PubMed ID: 31505088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
    Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
    Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.
    Darvishian M; Wong S; Binka M; Yu A; Ramji A; Yoshida EM; Wong J; Rossi C; Butt ZA; Bartlett S; Pearce ME; Samji H; Cook D; Alvarez M; Chong M; Tyndall M; Krajden M; Janjua NZ
    J Viral Hepat; 2020 Mar; 27(3):243-260. PubMed ID: 31664755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
    Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
    CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico.
    Carmody MD; Wagner K; Bizstray B; Thornton K; Fiuty P; Rosario AD; Teshale E; Page K
    Public Health Rep; 2023; 138(6):936-943. PubMed ID: 36633367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.